ApprovalTrail

Approval · Notice of Compliance 25654 · 2021

SIMPARICA: Notice of Compliance 25654

Issued April 13, 2021

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
25654
Date
April 13, 2021
Company
Zoetis Canada IncKirkland, Quebec, Canada
Product type
Veterinary
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
New indication

Products in this notice

BrandDINStatus today
SIMPARICA02452014Marketed
SIMPARICA02452022Marketed
SIMPARICA02452030Marketed
SIMPARICA02452049Marketed
SIMPARICA02452057Marketed
SIMPARICA02452065Marketed

Medicinal ingredients